The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Chemotherapy-induced thrombosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575 · cited 2×
“It is a synthetic derivative of glutamic acid that has demonstrated clear benefit in the treatment of refractory or relapsed multiple myeloma [56].”
BackgroundRisk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012385 · Cited by 1,052
Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., Dousset, B., Morel, P., Soubrane, O., Chaussade, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh095 · Cited by 1,038
Powles, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05071-5 · Cited by 902
Levitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Efficacy of Lenalidomide in Myelodysplastic Syndromes
List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041668 · Cited by 880
Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1535 · Cited by 835
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Richardson, P. G., Schlossman, R. L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., LeBlanc, R., Catley, L. P., Doss, D., Kelly, K., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0996 · Cited by 804
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.14 · Cited by 749
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
Corral, L. G., Haslett, P. A. J., Muller, G. W., Chen, R., Wong, L. M., Ocampo, C. J., Patterson, R. T., Stirling, D., & Kaplan, G. (1999) · PubMed · Cited by 729
(1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-690_2 · Cited by 662
Corral, L. G., Haslett, P. A. J., Muller, G. W., Chen, R., Wong, L.-M., Ocampo, C. J., Patterson, R. T., Stirling, D. I., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.380 · Cited by 656
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
Rajkumar, S. V., Hayman, S. R., Lacy, M. Q., Dispenzieri, A., Geyer, S. M., Kabat, B., Zeldenrust, S. R., Kumar, S., Greipp, P. R., Fonseca, R., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2817 · Cited by 648
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.445 · Cited by 594
The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate
Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Kehoe, S. T. (2002) · Neoplasia · doi:10.1038/sj.neo.7900263 · Cited by 576
Gupta, D., Treon, S., Shima, Y., Hideshima, T., Podar, K., Tai, Y., Lin, B., Lentzsch, S., Davies, F., Chauhan, D., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402295 · Cited by 553
Cancer and venous thromboembolism
Prandoni, P., Falanga, A., & Piccioli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70207-2 · Cited by 540
Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
Rajkumar, S. V., Hayman, S., Gertz, M. A., Dispenzieri, A., Lacy, M. Q., Greipp, P. R., Geyer, S., Iturria, N., Fonseca, R., Lust, J. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.116 · Cited by 512
Zangari, M., Anaissie, E., Barlogie, B., Badros, A., Desikan, R., Gopal, A. V., Morris, C., Toor, A., Siegel, E., Fink, L., et al. (2001) · Blood · doi:10.1182/blood.v98.5.1614 · Cited by 491
Vansteenkiste, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1211 · Cited by 477
Forbes, C. D. (1994) · Cited by 435
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
Wan, J., Nguyen, N., & Sallah, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613051 · Cited by 411
Structure and function of thrombomodulin: a natural anticoagulant
Dittman, W., & Majerus, P. (1990) · Blood · doi:10.1182/blood.v75.2.329.329 · Cited by 411
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
Saphner, T., Tormey, D. C., & Gray, R. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.2.286 · Cited by 396
Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production
Muller, G. W., Chen, R., Huang, S.-Y., Corral, L. G., Wong, L. M., Patterson, R. T., Chen, Y., Kaplan, G., & Stirling, D. I. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00250-4 · Cited by 341
Moore, K., Esmon, C., & Esmon, N. (1989) · Blood · doi:10.1182/blood.v73.1.159.159 · Cited by 336
Schey, S. A., Fields, P., Bartlett, J. B., Clarke, I. A., Ashan, G., Knight, R. D., Streetly, M., & Dalgleish, A. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.052 · Cited by 314
Raza, A., Meyer, P., Dutt, D., Zorat, F., Lisak, L., Nascimben, F., du Randt, M., Kaspar, C., Goldberg, C., Loew, J., et al. (2001) · Blood · doi:10.1182/blood.v98.4.958 · Cited by 305
Kuenen, B. C., Rosen, L. S., Smit, E. F., Parson, M., Levi, M. M., Ruijter, R., Huisman, H., Kedde, M. A., Noordhuis, P., van der Vijgh, W. J. F., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1657 · Cited by 279
The cardiovascular effects of erythropoietin
Smith, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00468-1 · Cited by 276
Zangari, M., Siegel, E., Barlogie, B., Anaissie, E., Saghafifar, F., Fassas, A., Morris, C., Fink, L., & Tricot, G. (2002) · Blood · doi:10.1182/blood-2002-01-0335 · Cited by 262
Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa
DVORAK, H. F., NAGY, J. A., BERSE, B., BROWN, L. F., YEO, K., YEO, T., DVORAK, A. M., VAN DE WATER, L., SIOUSAT, T. M., & SENGER, D. R. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51603.x · Cited by 232
Grignani, G., & Maiolo, A. T. (2000) · PubMed · Cited by 227
The tissue factor pathway of blood coagulation.
Nemerson, Y. (1992) · PubMed · Cited by 223
Zangari, M., Barlogie, B., Anaissie, E., Saghafifar, F., Eddlemon, P., Jacobson, J., Lee, C., Thertulien, R., Talamo, G., Thomas, T., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05078.x · Cited by 220
Giavazzi, R., Foppolo, M., Dossi, R., & Remuzzi, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116928 · Cited by 218
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue
Falanga, A., & Gordon, S. G. (1985) · Biochemistry · doi:10.1021/bi00341a041 · Cited by 210
Goodnough, L. T., Saito, H., Manni, A., Jones, P. K., & Pearson, O. H. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7<1264::aid-cncr2820540706>3.0.co;2-r · Cited by 202
Numico, G., Garrone, O., Dongiovanni, V., Silvestris, N., Colantonio, I., Di Costanzo, G., Granetto, C., Occelli, M., Fea, E., Heouaine, A., et al. (2005) · Cancer · doi:10.1002/cncr.20893 · Cited by 197
Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy
JACKSON, A. M., ROSE, B. D., GRAFF, L. G., JACOBS, J. B., SCHWARTZ, J. H., STRAUSS, G. M., YANG, J. P. S., RUDNICK, M. R., ELFENBEIN, I. B., & NARINS, R. G. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-41 · Cited by 184
The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient
Lee, A., & Levine, M. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994915 · Cited by 182
Priest, J. R., Ramsay, N. K. C., Steinherz, P. G., Tubergen, D. G., Cairo, M. S., Sitarz, A. L., Bishop, A. J., White, L., Trigg, M. E., Levitt, C. J., et al. (1982) · The Journal of Pediatrics · doi:10.1016/s0022-3476(82)80535-0 · Cited by 179
Tissue Factor in Health and Disease
Semeraro, N., & Colucci, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657625 · Cited by 177
Cardiotoxicity of the Antiproliferative Compound Fluorouracil
Becker, K., Erckenbrecht, J. F., aussinger, D. H., & Frieling, T. (1999) · Drugs · doi:10.2165/00003495-199957040-00003 · Cited by 172
Deitcher, S. R., & Gomes, M. P. V. (2004) · Cancer · doi:10.1002/cncr.20347 · Cited by 167
Dredge, K., Marriott, J. B., Todryk, S. M., Muller, G. W., Chen, R., Stirling, D. I., & Dalgleish, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4914 · Cited by 162
Falanga, A., Marchetti, M., Evangelista, V., Manarini, S., Oldani, E., Giovanelli, S., Galbusera, M., Cerletti, C., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.8.2506 · Cited by 158
Cancer and thromboembolic disease: pathogenic mechanisms
Lee, A. Y. Y. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00044-0 · Cited by 148
Apoptosis is associated with increased cell surface tissue factor procoagulant activity.
Greeno, E. W., Bach, R. R., & Moldow, C. F. (1996) · PubMed · Cited by 144
Self-citationBartlett, J. B., Michael, A., Clarke, I., Dredge, K. S., Nicholson, S., Kristeleit, H., Polychronis, A., Pandha, H. S., Muller, G. W., Stirling, D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601579 · Cited by 143
Cancer and venous thromboembolism: an overview.
Prandoni, P., Piccioli, A., & Girolami, A. (1999) · PubMed · Cited by 143
Wun, T., Law, L. Y., Harvey, D. J., Sieracki, B., Scudder, S., & Ryu, J. K. (2003) · Cancer · doi:10.1002/cncr.11700 · Cited by 139
Zangari, M., Saghafifar, F., Anaissie, E. J., Badros, A. Z., Desikan, R. K., Fassas, A., Mehta, P., Morris, C., Toor, A. A., Whitfield, D., et al. (2002) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200204000-00003 · Cited by 135
Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis
Heaton, D. C., Han, D. Y., & Inder, A. (2002) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2002.d01-28.x · Cited by 133
Adverse effects of thalidomide administration in patients with neoplastic diseases
Dimopoulos, M. A., & Eleutherakis-Papaiakovou, V. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.040 · Cited by 130
Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide
Dimopoulos, M. A., Zomas, A., Viniou, N. A., Grigoraki, V., Galani, E. P., Matsouka, C., Economou, O., Anagnostopoulos, N. I., & Panayiotidis, P. G. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3596 · Cited by 127
Fatal Pulmonary Embolism in Cancer Patients
Vs, S., & POLLAK, E. W. (1980) · Southern Medical Journal · doi:10.1097/00007611-198007000-00005 · Cited by 124
Minnema, M. C., Fijnheer, R., de Groot, P. G., & Lokhorst, H. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00083.x · Cited by 119
Shah, M. A., Ilson, D. H., & Kelsen, D. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.81.908 · Cited by 119
Desai, A. A., Vogelzang, N. J., Rini, B. I., Ansari, R., Krauss, S. A., & Stadler, W. M. (2002) · Cancer · doi:10.1002/cncr.10847 · Cited by 112
Bevacizumab in the Treatment of Breast Cancer: Rationale and Current Data
Rugo, H. S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_1-43 · Cited by 108
van Hinsbergh, V. W. M., Bauer, K. A., Kooistra, T., Kluft, C., Dooijewaard, G., Sherman, M., & Nieuwenhuizen, W. (1990) · Blood · doi:10.1182/blood.v76.11.2284.2284 · Cited by 107
Epidemiology of Oral Contraceptives and Cardiovascular Disease
Chasan‐Taber, L., & Stampfer, M. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00008 · Cited by 105
Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy
Levine, M. N. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657515 · Cited by 103
Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia
Barosi, G., Grossi, A., Comotti, B., Musto, P., Gamba, G., & Marchetti, M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02918.x · Cited by 96
Efficacy and safety of thalidomide in patients with acute myeloid leukemia
Steins, M. B., Padró, T., Bieker, R., Ruiz, S., Kropff, M. H., Kienast, J., Keßler, T., Büchner, T., Berdel, W. E., & Mesters, R. M. (2002) · Blood · doi:10.1182/blood.v99.3.834 · Cited by 95
Thrombogenic role of cells undergoing apoptosis
Wang, J., Weiss, I. M., Svoboda, K. M., & Kwaan, H. C. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03095.x · Cited by 86
Effect of Tamoxifen on Measurements of Hemostasis in Healthy Women
Mannucci, P. M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440150056006 · Cited by 82
Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy
Falanga, A. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022405 · Cited by 79
Mills, P. J., Parker, B. A., Jones, V. E., Adler, K. A., Perez, C. J., Johnson, S., Cohen‐Zion, M., Marler, M., Sadler, G. R., Dimsdale, J. E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0734-04 · Cited by 76
Ma, L., Francia, G., Viloria‐Petit, A., Hicklin, D. J., du Manoir, J. M., Rak, J. W., & Kerbel, R. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3156 · Cited by 75
Kwaan, H. C., & Keer, H. N. (1990) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002674 · Cited by 73
Cushman, M., Costantino, J. P., Bovill, E. G., Wickerham, D. L., Buckley, L. M., Roberts, J. D., & Krag, D. N. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03976.x · Cited by 70
Corso, A., Lorenzi, A., Terulla, V., Air�, F., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Rusconi, C., & Lazzarino, M. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0891-6 · Cited by 70
Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis
Barbul, T., Finazzi, G., Grassi, A., & Marchioli, R. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650276 · Cited by 70
Non-Small Cell Lung Cancer and Antiangiogenic Therapy: What Can Be Expected of Bevacizumab?
Herbst, R. S., & Sandler, A. B. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_1-19 · Cited by 69
Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels
Edwards, R. L., Klaus, M., Matthews, E., et al. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90093-s · Cited by 64
Lavey, R. S., Liu, P. Y., Greer, B. E., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.009 · Cited by 56
Marchi, S. D., Cecchin, E., Falleti, E., Giacomello, R., Stel, G., Sepiacci, G., Bortolotti, N., Zanello, F., Gonano, F., & Bartoli, E. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v871147 · Cited by 54
The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis
Pemberton, K. D., Melissari, E. N., & Kakkar, V. V. (1993) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199312000-00011 · Cited by 49
Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats
Koga, S., Kaibara, N., & Takeda, R. (1982) · Cancer · doi:10.1002/1097-0142(19820801)50:3<451::aid-cncr2820500312>3.0.co;2-4 · Cited by 43
Horne, M. K., Figg, W. D., Arlen, P. M., Gulley, J. L., Parker, C., Lakhani, N. J., Parnes, H. L., & Dahut, W. L. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.3.315.32106 · Cited by 40
Venous thromboembolism and cancer: new issues for an old topic
Mandalà, M. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00041-6 · Cited by 37
van Kleef, E., Verheij, M., Poele, H. T., et al. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)154[0375:ivaive]2.0.co;2 · Cited by 35
Streetly, M. J., Hunt, B. J., Parmar, K., Jones, R. W., Zeldis, J. B., & Schey, S. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00393.x · Cited by 30
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Metadata
- Authors
- Haddad, T. C., & Greeno, E. W.
- Venue
- Thrombosis Research
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 118
- Issue
- 5
- Pages
- 555-568
- ISSN
- 0049-3848 (ISSN-L)
- OpenAlex
- W2020579106
- Cited by
- 359
- References
- 99
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.